Celebrating Excellence in the Bleeding Disorders Community The Georgia World Congress Center in Atlanta buzzed with anticipation as the bleeding disorders community gathered for the pinnacle of the 2024 Bleeding Disorders Conference: The…
Findings of a new preclinical study published online in Nature Communications may help address lingering questions relevant to the long-term durability of approved hemophilia A gene therapy. The research was led by Lindsey A. George, director of…
The U.S. Food and Drug Administration (FDA) is holding a public webinar that will speak to the ways in which a strong support network can help mitigate some of the inherent challenges associated with clinical trial participation. Finding…
October 24, 2024 The Bleeding Disorders Association of South Carolina has provided a list of Hurricane Helene Resources and access to their disaster relief program. According to the chapter…
A recent communication has been released regarding the memorial service for the late Neil Frick, a cherished colleague whose passing has deeply affected the National Bleeding Disorders Foundation (NBDF) and the bleeding disorders community.Neil…
On October 11, 2024, Pfizer announced that the U.S. FDA approved HYMPAVZI™ (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults and pediatric individuals 12 years of age and older with…
Speaker: Lindsey A. George, MD Are you or a loved one affected by hemophilia A? Curious about cutting-edge treatments that could change lives? Join us for an exciting webinar where Dr. Lindsey A. George will shed…
Speakers:Katherine Bush, LCSW at the Hemophilia Center of Western Pennsylvania Shanna Garcia, Director of Development, Texas Central Bleeding DisordersSupporting Your Teen’s Mental Health: Key Strategies for Parents…